Shares of JetBlue Airways Corp. JBLU inched 0.14% higher to $7.05 Monday, on what proved to be an all-around mixed trading ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
CTLA-4 inhibitors are a well-established market in cancer care, and they are expected to grow significantly in the coming ...
When it comes to the best watches of 2024, there were some standout releases. This is a guide to top picks from Rolex, TAG ...
The evolution and improvisation of this class can be seen through the development of Fc-enhanced tumor-activated anti-CTLA-4 inhibitors (Xilio's Therapeutics' Vilastobart) which also deplete ...